Citation: | DAI M L, DONG J Y, PAN Y L, et al. Application of CT in the prognostic analysis of ureteral carcinoma[J]. CT Theory and Applications, 2022, 31(5): 679-685. DOI: 10.15953/j.ctta.2021.010. (in Chinese). |
[1] |
ROUPRET M, ZIGEUNERI R, PALOU J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update[J]. European Urology, 2011, 59(4): 584−594. doi: 10.1016/j.eururo.2010.12.042
|
[2] |
MARGULIS V, SHARIAT S F, MATIN S F, et al. Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration[J]. Cancer, 2009, 115(6): 1224−1233. doi: 10.1002/cncr.24135
|
[3] |
ROUPRET M, BABJUK M, COMPERAT E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update[J]. European Urology, 2018, 73(1): 111−122. doi: 10.1016/j.eururo.2017.07.036
|
[4] |
LEHMANN J, SUTTMANN H, KOVAC I, et al. Transitional cell carcinoma of the ureter: Prognostic factors influencing progression and survival[J]. European Urology, 2007, 51(5): 1281−1288. doi: 10.1016/j.eururo.2006.11.021
|
[5] |
PARIZI M K, GLYBOCHKO P V, ENIKEEV D, et al. Risk stratification of upper tract urothelial carcinoma: A review of the current literature[J]. Expert Review of Anticancer Therapy, 2019, 19(6): 503−513. doi: 10.1080/14737140.2019.1621753
|
[6] |
ABOUASSALY R, ALIBHAI S M H, SHAH N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma[J]. Urology, 2010, 76(4): 895−901. doi: 10.1016/j.urology.2010.04.020
|
[7] |
GAKIS G, WITJES J A, COMPERAT E, et al. EAU guidelines on primary urethral carcinoma[J]. European Urology, 2013, 64(5): 823−830. doi: 10.1016/j.eururo.2013.03.044
|
[8] |
安宁豫, 江波, 蔡幼铨, 等. 原发输尿管癌的MRI诊断并与其他影像诊断方法的比较[J]. 中华放射学杂志, 2004,38(8): 811−815. doi: 10.3760/j.issn:1005-1201.2004.08.006
AN N Y, JIANG B, CAI Y Q, et al. Primary ureteral carcinoma: MRI diagnosis and comparison with other diagnostic imaging facilities[J]. Chinese Journal of Radiology, 2004, 38(8): 811−815. (in Chinese). doi: 10.3760/j.issn:1005-1201.2004.08.006
|
[9] |
ROUPRET M, BABJUK M, COMPERAT E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update[J]. European Urology, 2013, 63(6): 1059−1071. doi: 10.1016/j.eururo.2013.03.032
|
[10] |
LI C C, CHANG T H, WU W J, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients[J]. European Urology, 2008, 54(5): 1127−1135. doi: 10.1016/j.eururo.2008.01.054
|
[11] |
万绪明, 侯艳玲, 于忠海. 原发性输尿管癌与输尿管转移癌的螺旋 CT 诊断[J]. 临床放射学杂志, 2010,29(7): 985−987.
WAN X M, HOU Y L, YU Z H. Helical CT diagnosis of the primary ureteral carcinoma and ureteral metastatic carcinoma[J]. Journal of Clinical Radiology, 2010, 29(7): 985−987. (in Chinese).
|
[12] |
张秀丽, 吕申, 王朝晖, 等. 输尿管癌“环/线”状CT强化征及其临床意义[J]. 中国医学影像技术, 2013,29(7): 1155−1159.
ZHANG X L, LV S, WANG C H, et al. CT imaging of ureteral carcinoma: A "ring/line" enhancement sign and its clinical significance[J]. Chinese Journal of Medical Imaging Technology, 2013, 29(7): 1155−1159. (in Chinese).
|
[13] |
FAVARETTO R L, SHARIAT S F, SAVAGE C, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma[J]. BJU International, 2012, 109(1): 77−82. doi: 10.1111/j.1464-410X.2011.10288.x
|
[14] |
COWAN N C, TURNEY B W, TAYLOR N J, et a1. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour[J]. BJU International, 2007, 99(6): 1363−1370. doi: 10.1111/j.1464-410X.2007.06766.x
|
[15] |
ZEIKUS E, SURA G, HINDMAN N, et a1. Tumors of renal collecting systems, renal pelvis, and ureters: Role of MR imaging and MR urography versus computed tomography urography[J]. Magnetic Resonance Imaging Clinics of North America, 2019, 27(1): 15−32. doi: 10.1016/j.mric.2018.09.002
|
[16] |
YAN S B, LIU L R, WEI Q, et al. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: A multi institutional analysis of 795 cases[J]. BJU International, 2016, 118(6): 902−910. doi: 10.1111/bju.13463
|
[17] |
MILOJEVIC B, DJOKIC M, MILENKOVIC D, et al. The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma[J]. European Urology Supplements, 2013, 12(4): e1219−S111.
|
[18] |
ZHANG X K, ZHANG Z L, YANG P, et al. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma[J]. Japanese Journal of Clinical Oncology, 2015, 45(11): 1069−1075. doi: 10.1093/jjco/hyv127
|
[19] |
LEE S E, HONG S K, HAN B K, et a1. Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract[J]. Japanese Journal of Clinical Oncology, 2007, 37(1): 49−55. doi: 10.1093/jjco/hyl123
|
[20] |
ZIGEUNER R, SHARIAT S F, MARGULIS V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract[J]. European Urology, 2010, 57(4): 575−581. doi: 10.1016/j.eururo.2009.11.035
|
[21] |
CHROMECKI T F, CHA E K, FAJKOVIC H, e al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy[J]. European Urology, 2012, 61(4): e75−e76.
|